Throughput flexibility adapts to expanding use cases.

@Injective $INJ #Injective
Injective’s real magic isn’t some flashy feature—it’s the fact that they built a single orderbook that just takes every major asset natively. No hoops to jump through, no wrapping, no bridges, no headaches. Traders can drop in a limit order with USDC from Ethereum, and someone else can fill it using staked INJ from Cosmos or USDT from Solana. It all happens in one transparent, unified book. That one simple design choice is why Injective’s real-world asset perpetuals crossed six billion dollars in volume by late November 2025. Open interest sits above 480 million dollars most days, and daily turnover often blasts past 170 million. Binance traders use this orderbook to run leveraged plays on tokenized Tesla, Nvidia, gold, EUR/USD—even pre-IPO contracts like OpenAI—confident that their collateral works as-is.
Everything about Injective’s liquidity layer revolves around this idea of native universality. Every market runs on a single, global central limit orderbook where collateral from Ethereum, Cosmos, Solana, and soon Monad, all gets treated equally. That wipes out the mess that comes with wrapped assets: no bridge failures, no de-pegs, no extra gas fees. You can execute a million-dollar order for tokenized Apple stock with less than one basis point of slippage because, to the book, liquidity is just liquidity—doesn’t matter where it’s from. Equities now make up more than seventy percent of all RWA perpetual volume. The “Magnificent Seven” stocks alone drove 2.4 billion dollars this year. Treasury perpetuals added another 363 million, and even niche markets like Nvidia H100 GPU rentals—only live since August—have already traded over 77 million. When you drop the collateral barriers, suddenly even the weirdest real-world resources become instantly liquid.
The launch of the native EVM mainnet on November 11, 2025, took this idea even further. Now, Ethereum devs can jump in and build on Injective, using the same orderbook, insurance fund, and Chainlink oracles that power everything else. The MultiVM Token Standard means INJ is native in both execution environments, so Solidity contracts can stake INJ for a real fifteen percent yield and still use that staked INJ as collateral for leverage. Seven weeks after the launch, Injective’s EVM layer logged over 22 million transactions and attracted 250+ Ethereum-native protocols that committed to dual deployment. More than forty new apps went live right at launch, including perpetuals on BlackRock’s BUIDL fund, which now has over 630 million dollars in supply—all with full, native collateral support.
INJ is the fuel that keeps this engine running. Every trade pays fees in INJ, doesn’t matter what you’re using for collateral. Sixty percent of all protocol revenue goes to monthly buybacks, burning tokens for good and paying out rewards to participants. The November burn alone torched 6.78 million INJ, worth almost 40 million dollars—the biggest yet. Staking rewards come straight from real trading, so that fifteen percent yield is actually sustainable. Pineapple Financial, the first public company to hold INJ at scale, has built up a 100 million dollar treasury since September 2025, using the token for yield and governance.
For traders on Binance, this feels totally seamless. Fund your position with whatever asset you want, see the full depth of the book, trade with almost no slippage, and keep custody of your collateral. For builders, Injective’s pre-built modules mean you can launch a new RWA market in days instead of months.
Injective didn’t just build another chain with wrapped assets. They built the first universal orderbook, where every major collateral is accepted in its native form, no questions asked.
So, which natively accepted collateral do you think will lead trading volume in 2026—Ethereum’s USDC, staked INJ, Solana’s USDT, or something else? Drop your thoughts below.